Catheter Related Blood Stream Infection
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Those who meets two conditions listed below are eligible to this trial 1. the patient has an implanted CVC catheter for long term use. The catheter includes but not limited to BrovIac Catheter Hickman Catheter Silascon catheter Implanted CV port. 2. Their doctor thinks the patient requires preservation of the catheter when treating the CRBSI.
Exclusion criteria
Exclusion criteria: Those who meet these conditions are excluded from the trial. 1. the catheter is not made of silicon 2. the patient has allergy to alcohol 3. the patient is pregnant 4. the patient is breastfeeding 5. the patient does not require CVC preservation therapy 6. the patient or the patient guardians do not consent to the trial 7. any patients whose doctor thinks is not eligible.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of successful preservation of the CVC catheter after each CRBSI event (success is defined as the affected catheter is safe to use at 4 weeks later to the initiation of the ELT to CRBSI without recurrence of CRBSI) | — |
Secondary
| Measure | Time frame |
|---|---|
| Occurrence rate of CRBSI. Successful rate to achieve of the negative blood culture. Relativity of each bacteria causing CRBSI and patients's background or success rate of preservation. Number of times to perform ELT until the catheter required replacement. Other events related to the catheter such as tunnel infection, complicated infection or breakage. | — |
Countries
Japan
Contacts
Keio University School of medicine, Department of Pediatric Surgery